3 active not recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 3 |
Follow Multiple System Atrophy: new trials by email Literature Review of Multiple System Atrophy trials Research Report on Multiple System Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GDNF Gene Therapy for Multiple System Atrophy AAV2-GDNF gene therapy, Sham (Placebo) Surgery - Multiple System Atrophy | Phase 1 | Active not recruiting | Brain Neurotherapy Bio, Inc. | 9 | 2023-10-03 | 2026-01-30 |
| Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA) hOMSC300 - Multiple System Atrophy, MSA - Multiple System Atrophy | Phase 1 | Active not recruiting | Cytora Ltd. | 10 | 2022-11-07 | 2025-01-29 |
| Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Trimethaphan, Placebo - Multiple System Atrophy, Orthostatic Hypotension | Phase 1 | Active not recruiting | Vanderbilt University | 2 | 2016-04-01 | 2026-03-13 |
Hypotension, Orthostatic (1) · Shy-Drager Syndrome (1)
Autonomic Nervous System Diseases (3) · Basal Ganglia Diseases (3) · Brain Diseases (3) · Central Nervous System Diseases (3) · Movement Disorders (3) · Nervous System Diseases (3) · Neurodegenerative Diseases (3) · Primary Dysautonomias (3) · Synucleinopathies (3) · Cardiovascular Diseases (2) · Hypotension (2) · Vascular Diseases (2) · Orthostatic Intolerance (1)
Sodium Chloride (1) · Surgical Procedures, Operative (1) · Trimethaphan (1) · salicylhydroxamic acid (1) · trimethaphan camsylate (1)
Brain Neurotherapy Bio, Inc. (1) · Cytora Ltd. (1) · Vanderbilt University (1)
United States (2) · Israel (1)